103 related articles for article (PubMed ID: 21276422)
81. Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.
Choi J; Corder NL; Koduru B; Wang Y
Free Radic Biol Med; 2014 Jul; 72():267-84. PubMed ID: 24816297
[TBL] [Abstract][Full Text] [Related]
82. NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.
Diebold BA; Smith SM; Li Y; Lambeth JD
Antioxid Redox Signal; 2015 Aug; 23(5):375-405. PubMed ID: 24512192
[TBL] [Abstract][Full Text] [Related]
83. BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells.
Herrera B; García-Álvaro M; Cruz S; Walsh P; Fernández M; Roncero C; Fabregat I; Sánchez A; Inman GJ
PLoS One; 2013; 8(7):e69535. PubMed ID: 23936038
[TBL] [Abstract][Full Text] [Related]
84. Neuroprotection for stroke: current status and future perspectives.
Minnerup J; Sutherland BA; Buchan AM; Kleinschnitz C
Int J Mol Sci; 2012; 13(9):11753-11772. PubMed ID: 23109881
[TBL] [Abstract][Full Text] [Related]
85. NADPH Oxidases NOXs and DUOXs as putative targets for cancer therapy.
Weyemi U; Redon CE; Parekh PR; Dupuy C; Bonner WM
Anticancer Agents Med Chem; 2013 Mar; 13(3):502-14. PubMed ID: 22931418
[TBL] [Abstract][Full Text] [Related]
86. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease.
Altenhöfer S; Kleikers PW; Radermacher KA; Scheurer P; Rob Hermans JJ; Schiffers P; Ho H; Wingler K; Schmidt HH
Cell Mol Life Sci; 2012 Jul; 69(14):2327-43. PubMed ID: 22648375
[TBL] [Abstract][Full Text] [Related]
87. NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS.
Cifuentes-Pagano E; Csanyi G; Pagano PJ
Cell Mol Life Sci; 2012 Jul; 69(14):2315-25. PubMed ID: 22585059
[TBL] [Abstract][Full Text] [Related]
88. Protein-tyrosine phosphatase 1B (PTP1B) deficiency confers resistance to transforming growth factor-β (TGF-β)-induced suppressor effects in hepatocytes.
Ortiz C; Caja L; Bertran E; Gonzalez-Rodriguez Á; Valverde ÁM; Fabregat I; Sancho P
J Biol Chem; 2012 May; 287(19):15263-74. PubMed ID: 22427664
[TBL] [Abstract][Full Text] [Related]
89. Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine (VAS2870).
Sun QA; Hess DT; Wang B; Miyagi M; Stamler JS
Free Radic Biol Med; 2012 May; 52(9):1897-902. PubMed ID: 22406319
[TBL] [Abstract][Full Text] [Related]
90. Targeting NADPH oxidases in vascular pharmacology.
Schramm A; Matusik P; Osmenda G; Guzik TJ
Vascul Pharmacol; 2012; 56(5-6):216-31. PubMed ID: 22405985
[TBL] [Abstract][Full Text] [Related]
91. The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms.
Sancho P; Bertran E; Caja L; Carmona-Cuenca I; Murillo MM; Fabregat I
Biochim Biophys Acta; 2009 Feb; 1793(2):253-63. PubMed ID: 18848961
[TBL] [Abstract][Full Text] [Related]
92. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
93. The NADPH oxidase inhibitor VAS2870 impairs cell growth and enhances TGF-β-induced apoptosis of liver tumor cells.
Sancho P; Fabregat I
Biochem Pharmacol; 2011 Apr; 81(7):917-24. PubMed ID: 21276422
[TBL] [Abstract][Full Text] [Related]
94. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
95. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity.
Carmona-Cuenca I; Roncero C; Sancho P; Caja L; Fausto N; Fernández M; Fabregat I
J Hepatol; 2008 Dec; 49(6):965-76. PubMed ID: 18845355
[TBL] [Abstract][Full Text] [Related]
96. Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells.
Caja L; Sancho P; Bertran E; Fabregat I
J Hepatol; 2011 Aug; 55(2):351-8. PubMed ID: 21147185
[TBL] [Abstract][Full Text] [Related]
97.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
98.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
